CLL17
Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL)
clinical trial
Source: Wikidata
← Back to UnAcronym1
Results for
CLL17
1 result
Exact matches
Direct matches for the acronym you searched.
General